Nuclear Magnetic Resonance-Based Lipidomics in the Assessment of Cardiometabolic Risk in Type 1 Diabetes: An Exploratory Analysis.
Serés-Noriega T, Ortega E, Perea V, Giménez M, Boswell L, Mariaca K, Font C, Mesa A, Viñals C, Blanco J, Vinagre I, Pané A, Esmatjes E, Conget I, Amor AJ.
Serés-Noriega T, et al. Among authors: mesa a.
Diabetes Ther. 2023 Mar;14(3):553-567. doi: 10.1007/s13300-023-01372-x. Epub 2023 Feb 3.
Diabetes Ther. 2023.
PMID: 36732434
Free PMC article.